ISDA

Deposition Date 2018-12-19

Release Date 2019-03-27

Last Version Date 2024-11-20

Entry Detail

PDB ID:

6QAB

Keywords:

HYDROLASE

Title:

Human Butyrylcholinesterase in complex with (S)-N-(1-((2-cycloheptylethyl)amino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl)-N,N-dimethylbutan-1-aminium

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Cricetulus griseus

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.49 Å

R-Value Free:

0.23

R-Value Work:

0.19

R-Value Observed:

0.19

Space Group:

I 4 2 2

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Cholinesterase
Gene (Uniprot):BCHE
Mutations:N45Q, N483Q, N509Q,N514Q, 558STOP
Chain IDs:A
Chain Length:557
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P06276 Pfam ID:PF00135 EC:3.1.1.8

Ligand Molecules

DMS

GOL

HUQ

MES

NAG

SO4

Primary Citation

Tryptophan-derived butyrylcholinesterase inhibitors as promising leads against Alzheimer's disease.

Meden, A, Knez, D, Jukic, M, Brazzolotto, X, Grsic, M, Pislar, A, Zahirovic, A, Kos, J, Nachon, F, Svete, J, Gobec, S, Groselj, U.Show

Chem.Commun.(Camb.) 55 3765 3768 (2019)

PMID: 30864579 DOI: 10.1039/c9cc01330j

Abstact

We have identified tryptophan-based selective nanomolar butyrylcholinesterase (BChE) inhibitors. They are defined according to their chemical modularity, novel binding mode revealed by five solved crystal structures with human BChE, low cytotoxicity, and predicted permeability of the blood-brain barrier. Altogether, these factors indicate their potential as unique lead compounds for symptomatic therapy against Alzheimer's disease.

Legend

Protein

Chemical

Disease

Primary Citation of related structures